Official Publications Regeneron Pharmaceuticals, Inc.
Equities
REGN
US75886F1075
Biotechnology & Medical Research
|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 529.24 USD | +1.42% |
|
+7.30% | -25.70% |
| 06-13 | 23andMe's founder Anne Wojcicki wins bid for bankrupt DNA testing firm | RE |
| 06-13 | 23Andme Reaches Agreement For Sale Of Business To TTAM Research Institute | RE |
Official Publications
| SEC Filing 10Q-1 | 04-28 | CO |
| SEC Filing 8K | 04-28 | CO |
| 1st quarter results | 04-28 | CO |
| SEC Filing 10K | 02-04 | CO |
| Annual results | 02-03 | CO |
| Slide show results | 02-03 | CO |
| 3rd quarter results | 30/10/24 | CO |
| Slide show Q3 | 30/10/24 | CO |
| SEC Filing 8K | 30/10/24 | CO |
| SEC Filing 10Q-3 | 30/10/24 | CO |
| SEC Filing 10Q-2 | 31/07/24 | CO |
| Slide show half-year results | 31/07/24 | CO |
| 1st-half-year results | 31/07/24 | CO |
| Slide show Q1 | 01/05/24 | CO |
| 1st quarter results | 01/05/24 | CO |
| SEC Filing 10Q-1 | 01/05/24 | CO |
| SEC Filing 8K | 01/05/24 | CO |
| SEC Filing 10K | 04/02/24 | CO |
| SEC Filing 8K | 01/02/24 | CO |
| Annual results | 01/02/24 | CO |
| SEC Filing 8K | 30/01/24 | CO |
| SEC Filing 8K | 01/11/23 | CO |
| 3rd quarter results | 01/11/23 | CO |
| SEC Filing 10Q-3 | 01/11/23 | CO |
| Slide show Q3 | 01/11/23 | CO |
- Stock Market
- Equities
- REGN Stock
- News Regeneron Pharmaceuticals, Inc.
- Official Publications
Select your edition
All financial news and data tailored to specific country editions
MarketScreener is also available in this country: United States.
Switch edition
Stay in the current country edition